DSM Nutrition's Hamilton Sees Complementary Benefits In Martek Deal
This article was originally published in The Tan Sheet
Executive Summary
Royal DSM N.V. strengthened its identity as a life and material sciences company in late 2010 with its $1.09 billion purchase of Martek Biosciences.
You may also be interested in...
Sales & Earnings In Brief
Glaxo previews streamlined consumer unit
Sales & Earnings In Brief
Glaxo previews streamlined consumer unit
Sales & Earnings In Brief
Glaxo previews streamlined consumer unit